Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke

International Journal of Stroke

Volumn 10, Issue 5, 2015, Pages 752-758

  Zhao, Lu ^a   Wang, Ruihao ^a,b   Song, Bo ^a   Tan, Song ^c   Gao, Yuan ^a   Fang, Hui ^a   Lu, Jie ^d   Xu, Yuming ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d ZHENGZHOU UNIVERSITY   (China)

Author keywords

Atherogenic dyslipidemia; Ischemic stroke; Recurrent event

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERY OCCLUSION; ARTICLE; ATHEROGENIC DYSLIPIDEMIA; BODY MASS; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLISM; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EMBOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LARGE ARTERY ATHEROSCLEROSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; SMALL ARTERY OCCLUSION; AGED; ATHEROSCLEROSIS; CLASSIFICATION; COMPLICATION; DYSLIPIDEMIAS; FACTUAL DATABASE; FOLLOW UP; KAPLAN MEIER METHOD; MIDDLE AGED; NONPARAMETRIC TEST; RECURRENT DISEASE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BRAIN ISCHEMIA; DATABASES, FACTUAL; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; STATISTICS, NONPARAMETRIC; STROKE;

EID: 84931577397     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12471     Document Type: Article

References (29)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371:1612-1623.
2. Davis SM, Donnan GA. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med 2012; 366:1914-1922.
3. Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke 2007; 38:1881-1885.
4. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009; 8:453-463.
5. Fruchart JC, Sacks F, Hermans MP etal. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008; 102:1K-34K.
6. Arca M, Montali A, Valiante S etal. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Am J Cardiol 2007; 100:1511-1516.
7. Sirimarco G, Deplanque D, Lavallee PC etal. Atherogenic dyslipidemia in patients with transient ischemic attack. Stroke 2011; 42:2131-2137.
8. Sirimarco G, Labreuche J, Bruckert E etal. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke 2014; 45:1429-1436.
9. Saeed M. Editorial comment - unraveling the pagodian architecture of stroke as a complex disorder. Stroke 2004; 35:824-825.
10. Song B, Fang H, Zhao L etal. Validation of the ABCD3-I score to predict stroke risk after transient ischemic attack. Stroke 2013; 44:1244-1248.
11. Stroke - 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 1989; 20:1407-1431.
12. Brott T, Adams HP Jr, Olinger CP etal. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20:864-870.
13. Adams HP Jr, Bendixen BH, Kappelle LJ etal. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
14. Lee M, Saver JL, Towfighi A, Chow J, Ovbiagele B. Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis. Atherosclerosis 2011; 217:492-498.
15. Cabre A, Babio N, Lazaro I etal. FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis 2012; 222:229-234.
16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
17. Kuwashiro T, Sugimori H, Ago T, Kamouchi M, Kitazono T. Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset: the Fukuoka Stroke Registry. Cerebrovasc Dis 2012; 33:141-149.
18. Amarenco P, Goldstein LB, Callahan A 3rd etal. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis 2009; 204:515-520.
19. Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke 2003; 34:1457-1463.
20. Shin DH, Lee PH, Bang OY. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Arch Neurol 2005; 62:1232-1237.
21. Kumral E, Evyapan D, Gokcay F, Karaman B, Orman M. Association of baseline dyslipidemia with stroke recurrence within five-years after ischemic stroke. Int J Stroke 2014; 9(Suppl. A100):119-126.
22. Bang OY, Saver JL, Liebeskind DS, Pineda S, Ovbiagele B. Association of serum lipid indices with large artery atherosclerotic stroke. Neurology 2008; 70:841-847.
23. Turan TN, Makki AA, Tsappidi S etal. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke 2010; 41:1636-1640.
24. Qian Y, Pu Y, Liu L etal. Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study. PLoS ONE 2013; 8:e64395.
25. Jackson CA, Hutchison A, Dennis MS etal. Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy? Stroke 2010; 41:624-629.
26. Bezerra DC, Sharrett AR, Matsushita K etal. Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology 2012; 78:102-108.
27. Ginsberg HN, Elam MB, Lovato LC etal. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362:1563-1574.
28. Schulz UG, Rothwell PM. Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 2003; 34:2050-2059.
29. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995; 48:1503-1510.